1972
DOI: 10.1016/s0140-6736(72)90846-x
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous Salbutamol and Cardiogenic Shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

1974
1974
1990
1990

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(5 citation statements)
references
References 3 publications
0
5
0
Order By: Relevance
“…These findings are consistent with those of Nayler (1971) in respect of a direct coronary vasodilator effect of salbutamol and of Nayler & McInnes (1972) in regard to the maintenance of myocardial efficiency with salbutamol. The findings also lend encouragement to the further evaluation of salbutamol as a therapeutic aid in states of low cardiac output (Gibson & Colthart, 1971;Lal et al, 1972;Wyse, Gibson & Branthwaite, 1974;Sharma et al, 1976).…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…These findings are consistent with those of Nayler (1971) in respect of a direct coronary vasodilator effect of salbutamol and of Nayler & McInnes (1972) in regard to the maintenance of myocardial efficiency with salbutamol. The findings also lend encouragement to the further evaluation of salbutamol as a therapeutic aid in states of low cardiac output (Gibson & Colthart, 1971;Lal et al, 1972;Wyse, Gibson & Branthwaite, 1974;Sharma et al, 1976).…”
Section: Discussionmentioning
confidence: 79%
“…1971;Turnheim & Kraupp, 1971). There is some evidence that salbutamol is of therapeutic value in low output states due to cardiogenic shock (Gibson & Coltart, 1971;Lal, Savidge, Davies, Ali & Soni, 1972;Wyse, Gibson & Branthwaite, 1974;Sharma, Goodwin & Steiner. 1976).…”
Section: Introductionmentioning
confidence: 99%
“…Salbutamol, a f2-adrenergic receptor agonist has been shown to improve left ventricular function in patients with acute low cardiac output syndromes (Lal, Savidge, Davies Ali & Soni, 1972;Yacoub & Boyland, 1973;Wyse, Gibson & Branthwaite, 1974) and chronic congestive cardiac failure (Sharma, Goodwin & Steiner, 1977). This agent has a relatively prolonged duration of action after intravenous administration which is a disadvantage in the management of acutely ill patients with cardiac failure.…”
Section: Introduction Methodsmentioning
confidence: 99%
“…A previous investigation (Gibson and Coltart, 1971) indicated that these effects would be less marked when a comparable increase in cardiac output was brought about by salbutamol infusion, and the authors suggested that the drug might be of value in the treatment of low output states due to cardiogenic shock. Acting on this Lal et al (1972) claimed clinical evidence of improvement in nine out of 12 patients suffering from cardiogenic shock after myocardial infarction who were treated with intravenous injections of salbutamol (1-2 mg). The present study was designed to investigate the effect of substituting salbutamol for isoprenaline in a group of patients whose clinical condition needed circulatory support after open-heart surgery.…”
Section: Introductionmentioning
confidence: 99%